Bausch Health Cos Inc (NYSE: BHC) stock closed at $6.54 on 2/6/25 after a major decline of -10.9%. Moreover, this decline was accompanied by above average trading volume at 140% of normal. Relative to the market the stock has been strong over the last nine months but has declined -12.4% during the last week.
Current PriceTarget Research Rating
Bausch Health is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment